Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis

This study has been completed.
Information provided by:
Zosano Pharma Inc. Identifier:
First received: June 19, 2007
Last updated: May 7, 2009
Last verified: May 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):